Drugs Information: Belimumab
Basic Information
|
||
| ID | DDInter173 | |
| Drug Type | biotech | |
| Molecular Formula | C6358H9904N1728O2010S44 | |
| Molecular Weight | - | |
| Description | Belimumab is a B-lymphocyte stimulator (BLyS)-specific inhibitor that indirectly inhibits B cell survival, and is used to treat patients with autoantibody positive, active systemic lupus erythematosus. | |
| ATC Classification | L04AA26 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Belimumab
| Severity level | ID | Name | Mechanism | Detail |
|---|